What is the purpose of this trial?
The primary investigational aim of this study is to determine whether increasing genetic dose of schizophrenia-associated risk alleles at the C4 gene are associated (negatively correlated) with regional synaptic density in the living human brain as measured by 11C-UCB-J PET.
Ages: 18 - 55 years
Brain and Behavior Research Foundation
Start Date: 04/02/2018
End Date: 01/31/2023
Last Updated: 10/11/2018
Study HIC#: 2000022444